Treprostinil Synthesis Using Mild Oxidation to Reduce Toxic Byproducts
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods for synthesizing Treprostinil, a prostacyclin derivative, face issues such as the use of toxic oxidation reagents, reduced yields, elevated impurities, poor scalability, and the need for multiple chromatography steps, making them inefficient and costly.
Innovation Solution
The development of processes using less toxic oxidizing agents like MnO2 or Dess-Martin periodinane, which improve yields and reduce byproducts, and eliminate the need for additional chromatography, enabling the scalable production of Treprostinil with high chemical purity and enantiomeric excess.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If traditional oxidation reagents (e.g., oxalyl chloride) are used in prostacyclin synthesis, then the synthesis can proceed, but toxic byproducts are generated and safety issues arise
Solution Approach 1:
The patent changes the chemical parameters of the oxidation step by replacing traditional reagents (oxalyl chloride, mCPBA) with alternative oxidizing agents including electrochemical oxidation, chemical oxidation with H2O2 or PhI(OAc)2, and enzymatic oxidation. This parameter change eliminates toxic byproducts while maintaining synthesis effectiveness.
Solution Approach 2:
The patent employs electrochemical oxidation as a disposable, in-situ generated oxidation method that avoids the need for isolating and handling toxic oxidation reagents. The oxidation occurs directly in the reaction medium, eliminating waste disposal issues.
2Productivity
If traditional synthesis methods are used, then prostacyclin can be produced, but yields are reduced and impurities increase
Solution Approach 1:
The patent segments the synthesis into distinct modules with optimized conditions for each step. The oxidation step is separated and optimized independently using mild reagents that prevent side reactions, thereby improving both yield and purity of intermediates carrying stereocenters.
Solution Approach 2:
The patent uses mild oxidation intermediaries (H2O2, PhI(OAc)2, enzymatic systems) that selectively oxidize the desired substrates without causing side reactions. These intermediaries act as gentle mediators that preserve the integrity of sensitive functional groups, reducing impurity formation.
3Manufacturing precision
If traditional purification methods (chromatography) are used, then intermediates can be purified, but the process becomes complex and time-consuming
Solution Approach 1:
The patent extracts the purification requirement by designing reactions that inherently produce high-purity intermediates without requiring chromatography. The mild oxidation conditions prevent side product formation, and simple filtration or extraction suffices for purification.
Solution Approach 2:
The reaction system self-purifies by selectively forming the desired product with high stereochemical fidelity. The mild conditions prevent racemization and side reactions, so the crude product is sufficiently pure for the next step without additional purification.
4Quantity of substance
If traditional synthesis processes are scaled up, then commercial quantities can be produced, but scalability remains poor
Solution Approach 1:
The patent develops a universal oxidation platform that can be applied to multiple prostacyclin analogs and intermediates. The same mild oxidation conditions (electrochemical, H2O2, PhI(OAc)2, enzymatic) work across different substrates, enabling consistent scaling from lab to commercial production.
Solution Approach 2:
The patent changes the oxidation parameters to be more scalable by using reagents and conditions that are easier to handle at large scale (H2O2, electrochemical methods) compared to traditional reagents. The reactions proceed under milder conditions that are more amenable to continuous processing and large-scale manufacturing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These processes generate Treprostinil with improved yields, reduced impurities, and enhanced scalability, producing high-purity compounds efficiently, addressing the limitations of traditional methods.
Implementation Method 1
reacting a compound of Formula 9 with an oxidizing agent in the presence of an organic solvent to generate a compound of Formula 10
Implementation Method 2
reacting a compound of Formula 9 with an oxidizing agent in the presence of an organic solvent to generate a compound of Formula 10
Data Source
AI summary
The present invention provides processes for preparing a prostacyclin analogue of Formula I or a pharmaceutically acceptable salt thereof, wherein R10 is a linear or branched C1-6 alkyl. The processes of the present invention comprise steps that generate improved yields and fewer byproducts than traditional methods. The processes of the present invention employ reagents (e.g., the oxidizing reagent) that are less toxic that those used in the traditional methods (e.g., oxalyl chloride). Many of the processes of the present invention generate intermediates with improved e.e. and chemical purity; thereby eliminating the need of additional chromatography steps. And, the processes of the present invention are scalable to generate commercial quantities of the final compound.